Chemical stock which is one of the leading research and development-driven manufacturers of Advanced Pharmaceutical Intermediates and specialty chemicals in focus after SBI Mutual Fund picks a stake in it.
Price Action
With a market capitalization of Rs. 5,522 Crores, the shares of Ami Organics Limited were trading at Rs. 1,356 per equity share, up 0.44 percent from its previous day’s close price of Rs. 1,350.
What Happened
As per the Bulk deal data available on BSE, On August 1, 2024, SBI Mutual Fund purchased ~11.62 Lakh equity shares of Ami Organics Limited at an average price of Rs. 1,350 per equity share, while Plutus Wealth Management LLP sold 10 Lakh equity shares of the firm at same price levels.
About the Company
AMI Organics Limited (AMI) is one of the leading research and development-driven manufacturers of specialty chemicals, focused on the development and manufacturing of advanced pharmaceutical intermediates for regulated and generic active pharmaceutical ingredients, New Chemical Entities, and key starting materials for agrochemical and fine chemicals.
Ami Organics Limited has a presence across ~45 countries with 56 percent of revenue from exports. As of FY24, Ami Organics Limited generated 79 percent of its revenue from Advanced Pharmaceutical Intermediates and 21 percent from Specialty Chemicals.
FII Increase
In Q1FY25 the FII/FPI increased their holding in Ami Organics Limited from 8.98 percent in Q4FY24 to 12.93 percent in Q1FY25 by purchasing an additional 3.95 percent stake
Ace Investor Investment
Ace Investor Ashish Kacholia Holds a 1.85 percent stake in the company consisting of ~7.55 lakh equity shares. He made an entry into this company in the September 2021 Quarter by purchasing a 1.35 percent stake consisting of 4.91 lakh equity shares.
Financials and Ratios
Its revenue from operations grew by 16.33 percent from Rs. 617 Crores in FY23 to Rs. 717 Crores in FY24, accompanied by profits of Rs. 83 Crores to Rs. 49 Crores.
In terms of Return ratios, it has delivered a return on equity(ROE) of 9.39 percent and a return on capital employed (ROCE) of 16 percent. It has maintained a debt-to-equity ratio of 0.32.
Written by: Bharath K.S
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
